妊娠期药物治疗:牙髓病学视角
妊娠女性牙源性疼痛患病率高达54.9%,常与牙髓及根尖周感染相关。美国牙科协会与美国妇产科学院发布共识声明强调孕期及时口腔保健的重要性。本文由牙髓病学、儿童口腔科和产科专家合作,综述牙髓治疗常用药物(局麻药、镇痛药、抗焦虑药和抗生素)的安全性证据。
要点
- 妊娠期牙源性疼痛患病率可达54.9%,与牙髓根尖周感染相关
- 孕期避免牙髓治疗常源于对操作安全性和用药知识的不足
- 本文综述牙髓常用局麻药、镇痛药、抗焦虑药和抗生素的安全性证据
核心结论
- 孕期牙髓治疗相关药物安全性需基于现有证据评估,以避免不必要的治疗回避。
研究设计与样本
- 本文为牙髓病学、儿童口腔科和产科专家合作撰写的综述。
主要发现
- 牙源性疼痛影响高达54.9%的妊娠女性。
- 牙髓及根尖周感染对孕妇和胎儿构成风险。
关键数值与推荐
- 美国牙科协会与美国妇产科学院合作制定共识声明,确认孕期及时适当口腔保健的重要性。
临床怎么用
- 口腔科医生应了解牙髓常用药物在妊娠期的安全性证据,避免因知识不足而回避必要治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Odontogenic pain affects up to 54.9% of pregnant women1-3. This pain is often associated with pulpal and/or periapical infections that pose risks to women and their fetus. The American Dental Association in collaboration with the American College of Obstetricians and Gynecologists developed a consensus statement to affirm the importance of timely and appropriate oral health care as a critical component of a healthy pregnancy4. However, limited knowledge of endodontic procedure safety and related medication use often result in the avoidance of treatment during pregnancy. This article, a collaborative effort by specialists from endodontics, pediatric dentistry, and obstetrics, reviews the current evidence on the safety of medications commonly used in endodontics including local anesthetics, analgesics, anxiolytics, and antibiotics.
引用
- Ather A, Zhong S, Rosenbaum AJ, et al. Pharmacotherapy during Pregnancy: An Endodontic Perspective. J Endod. 2020. PMID: 32590023. doi:10.1016/j.joen.2020.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。